These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 26202849)

  • 1. Tumour necrosis factor receptor I blockade shows that TNF-dependent and TNF-independent mechanisms synergise in TNF receptor associated periodic syndrome.
    Fairclough LC; Stoop AA; Negm OH; Radford PM; Tighe PJ; Todd I
    Eur J Immunol; 2015 Oct; 45(10):2937-44. PubMed ID: 26202849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patients with tumour necrosis factor (TNF) receptor-associated periodic syndrome (TRAPS) are hypersensitive to Toll-like receptor 9 stimulation.
    Negm OH; Singh S; Abduljabbar W; Hamed MR; Radford P; McDermott EM; Drewe E; Fairclough L; Todd I; Tighe PJ
    Clin Exp Immunol; 2019 Sep; 197(3):352-360. PubMed ID: 31009059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concerted action of wild-type and mutant TNF receptors enhances inflammation in TNF receptor 1-associated periodic fever syndrome.
    Simon A; Park H; Maddipati R; Lobito AA; Bulua AC; Jackson AJ; Chae JJ; Ettinger R; de Koning HD; Cruz AC; Kastner DL; Komarow H; Siegel RM
    Proc Natl Acad Sci U S A; 2010 May; 107(21):9801-6. PubMed ID: 20457915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pro-inflammatory signalome is constitutively activated by C33Y mutant TNF receptor 1 in TNF receptor-associated periodic syndrome (TRAPS).
    Negm OH; Mannsperger HA; McDermott EM; Drewe E; Powell RJ; Todd I; Fairclough LC; Tighe PJ
    Eur J Immunol; 2014 Jul; 44(7):2096-110. PubMed ID: 24668260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling of tumor necrosis factor receptor superfamily 1A mutants associated with tumor necrosis factor receptor-associated periodic syndrome indicates misfolding consistent with abnormal function.
    Rebelo SL; Bainbridge SE; Amel-Kashipaz MR; Radford PM; Powell RJ; Todd I; Tighe PJ
    Arthritis Rheum; 2006 Aug; 54(8):2674-87. PubMed ID: 16871532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutant forms of tumour necrosis factor receptor I that occur in TNF-receptor-associated periodic syndrome retain signalling functions but show abnormal behaviour.
    Todd I; Radford PM; Draper-Morgan KA; McIntosh R; Bainbridge S; Dickinson P; Jamhawi L; Sansaridis M; Huggins ML; Tighe PJ; Powell RJ
    Immunology; 2004 Sep; 113(1):65-79. PubMed ID: 15312137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRAPS mutations in
    Akagi T; Hiramatsu-Asano S; Ikeda K; Hirano H; Tsuji S; Yahagi A; Iseki M; Matsuyama M; Mak TW; Nakano K; Ishihara K; Morita Y; Mukai T
    Front Immunol; 2022; 13():926175. PubMed ID: 35936010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic and Pharmacodynamic Characterisation of an Anti-Mouse TNF Receptor 1 Domain Antibody Formatted for In Vivo Half-Life Extension.
    Goodall LJ; Ovecka M; Rycroft D; Friel SL; Sanderson A; Mistry P; Davies ML; Stoop AA
    PLoS One; 2015; 10(9):e0137065. PubMed ID: 26352810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TNFRSF1A mutations and autoinflammatory syndromes.
    Galon J; Aksentijevich I; McDermott MF; O'Shea JJ; Kastner DL
    Curr Opin Immunol; 2000 Aug; 12(4):479-86. PubMed ID: 10899034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel markers of inflammation identified in tumor necrosis factor receptor-associated periodic syndrome (TRAPS) by transcriptomic analysis of effects of TRAPS-associated tumor necrosis factor receptor type I mutations in an endothelial cell line.
    Rebelo SL; Amel-Kashipaz MR; Radford PM; Bainbridge SE; Fiets R; Fang J; McDermott EM; Powell RJ; Todd I; Tighe PJ
    Arthritis Rheum; 2009 Jan; 60(1):269-80. PubMed ID: 19116900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The novel S59P mutation in the TNFRSF1A gene identified in an adult onset TNF receptor associated periodic syndrome (TRAPS) constitutively activates NF-κB pathway.
    Greco E; Aita A; Galozzi P; Gava A; Sfriso P; Negm OH; Tighe P; Caso F; Navaglia F; Dazzo E; De Bortoli M; Rampazzo A; Obici L; Donadei S; Merlini G; Plebani M; Todd I; Basso D; Punzi L
    Arthritis Res Ther; 2015 Apr; 17(1):93. PubMed ID: 25888769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autophagy contributes to inflammation in patients with TNFR-associated periodic syndrome (TRAPS).
    Bachetti T; Chiesa S; Castagnola P; Bani D; Di Zanni E; Omenetti A; D'Osualdo A; Fraldi A; Ballabio A; Ravazzolo R; Martini A; Gattorno M; Ceccherini I
    Ann Rheum Dis; 2013 Jun; 72(6):1044-52. PubMed ID: 23117241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TNFR1-d2 carrying the p.(Thr79Met) pathogenic variant is a potential novel actor of TNFα/TNFR1 signalling regulation in the pathophysiology of TRAPS.
    Rittore C; Méchin D; Sanchez E; Marinèche L; Ea V; Soler S; Vereecke M; Mallavialle A; Richard E; Duroux-Richard I; Apparailly F; Touitou I; Grandemange S
    Sci Rep; 2021 Feb; 11(1):4172. PubMed ID: 33603056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A signalome screening approach in the autoinflammatory disease TNF receptor associated periodic syndrome (TRAPS) highlights the anti-inflammatory properties of drugs for repurposing.
    Todd I; Negm OH; Reps J; Radford P; Figueredo G; McDermott EM; Drewe E; Powell RJ; Bainbridge S; Hamed M; Crouch S; Garibaldi J; St-Gallay S; Fairclough LC; Tighe PJ
    Pharmacol Res; 2017 Nov; 125(Pt B):188-200. PubMed ID: 28860008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of TNF receptor superfamily 1 (TNFR1)-dependent and TNFR1-independent cell death is crucial for normal epidermal differentiation.
    Piao X; Miura R; Miyake S; Komazawa-Sakon S; Koike M; Shindo R; Takeda J; Hasegawa A; Abe R; Nishiyama C; Mikami T; Yagita H; Uchiyama Y; Nakano H
    J Allergy Clin Immunol; 2019 Jan; 143(1):213-228.e10. PubMed ID: 29596938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Candidate genes in patients with autoinflammatory syndrome resembling tumor necrosis factor receptor-associated periodic syndrome without mutations in the TNFRSF1A gene.
    Borghini S; Fiore M; Di Duca M; Caroli F; Finetti M; Santamaria G; Ferlito F; Bua F; Picco P; Obici L; Martini A; Gattorno M; Ceccherini I
    J Rheumatol; 2011 Jul; 38(7):1378-84. PubMed ID: 21459945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Revisiting TNF Receptor-Associated Periodic Syndrome (TRAPS): Current Perspectives.
    Cudrici C; Deuitch N; Aksentijevich I
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32380704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The tumour necrosis factor receptor-associated periodic syndrome: current concepts.
    Stojanov S; McDermott MF
    Expert Rev Mol Med; 2005 Oct; 7(22):1-18. PubMed ID: 16216134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Falling into TRAPS--receptor misfolding in the TNF receptor 1-associated periodic fever syndrome.
    Kimberley FC; Lobito AA; Siegel RM; Screaton GR
    Arthritis Res Ther; 2007; 9(4):217. PubMed ID: 17666110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal disulfide-linked oligomerization results in ER retention and altered signaling by TNFR1 mutants in TNFR1-associated periodic fever syndrome (TRAPS).
    Lobito AA; Kimberley FC; Muppidi JR; Komarow H; Jackson AJ; Hull KM; Kastner DL; Screaton GR; Siegel RM
    Blood; 2006 Aug; 108(4):1320-7. PubMed ID: 16684962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.